nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Angiotensin II type I receptor antibodies in pediatric solid organ transplant
|
Pearl, Meghan H. |
|
2019 |
80 |
8 |
p. 568-572 |
artikel |
2 |
Angiotensin II type I receptor antibodies in thoracic transplantation
|
Zhang, Xiaohai |
|
2019 |
80 |
8 |
p. 579-582 |
artikel |
3 |
Antibodies against Angiotensin II Type 1 and Endothelin A Receptors: Relevance and pathogenicity
|
Philogene, Mary Carmelle |
|
2019 |
80 |
8 |
p. 561-567 |
artikel |
4 |
Anti-vimentin antibodies in transplant and disease
|
Divanyan, Tigran |
|
2019 |
80 |
8 |
p. 602-607 |
artikel |
5 |
Clinical relevance of lung-restricted antibodies in lung transplantation
|
Akbarpour, Mahzad |
|
2019 |
80 |
8 |
p. 595-601 |
artikel |
6 |
Compelling scientific and clinical evidence that non-HLA specific antibodies impact graft outcome independently and in concert with donor HLA specific antibodies
|
Reinsmoen, Nancy L. |
|
2019 |
80 |
8 |
p. 555-560 |
artikel |
7 |
Injury derived autoimmunity: Anti-perlecan/LG3 antibodies in transplantation
|
Dieudé, Mélanie |
|
2019 |
80 |
8 |
p. 608-613 |
artikel |
8 |
Proactive treatment of angiotensin receptor antibodies in kidney transplantation with plasma exchange and/or candesartan is safe and associated with excellent graft survival at 4 years: A single centre Australian experience
|
Carroll, Robert P |
|
2019 |
80 |
8 |
p. 573-578 |
artikel |
9 |
Sensitization to endothelial cell antigens: Unraveling the cause or effect paradox
|
Jackson, Annette M. |
|
2019 |
80 |
8 |
p. 614-620 |
artikel |
10 |
The impact of non-HLA antibodies on outcomes after lung transplantation and implications for therapeutic approaches
|
Hachem, Ramsey R. |
|
2019 |
80 |
8 |
p. 583-587 |
artikel |
11 |
The role of donor-derived exosomes in lung allograft rejection
|
Ravichandran, Ranjithkumar |
|
2019 |
80 |
8 |
p. 588-594 |
artikel |